Hamilton Lane (NASDAQ:HLNE – Get Free Report) had its target price raised by research analysts at UBS Group from $115.00 to $120.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group‘s target price would indicate a potential upside of 33.14% from the company’s previous close.
HLNE has been the topic of several other reports. Wells Fargo & Company boosted their price target on shares of Hamilton Lane from $103.00 to $114.00 and gave the stock an “overweight” rating in a research report on Wednesday. Morgan Stanley set a $118.00 price objective on Hamilton Lane in a report on Friday, October 16th. JPMorgan Chase & Co. lowered their target price on Hamilton Lane from $150.00 to $144.00 and set an “overweight” rating on the stock in a research report on Wednesday. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $117.00 target price on shares of Hamilton Lane in a research report on Friday, October 2nd. Finally, Oppenheimer reduced their price target on Hamilton Lane from $182.00 to $181.00 and set an “outperform” rating for the company in a research report on Thursday, August 27th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $126.12.
Check Out Our Latest Research Report on HLNE
Hamilton Lane Stock Down 5.1%
Shares of HLNE stock traded down $4.86 during trading on Thursday, reaching $90.13. The company’s stock had a trading volume of 760,567 shares, compared to its average volume of 770,919. The business has a fifty day moving average price of $90.06 and a 200-day moving average price of $97.21. The company has a quick ratio of 3.49, a current ratio of 3.37 and a debt-to-equity ratio of 0.14. The company has a market cap of $5.01 billion, a price-to-earnings ratio of 13.37 and a beta of 1.16. Hamilton Lane has a one year low of $71.88 and a one year high of $155.66.
Hamilton Lane (NASDAQ:HLNE – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $1.98 EPS for the quarter, topping the consensus estimate of $1.65 by $0.33. The business had revenue of $204.43 million during the quarter, compared to analysts’ expectations of $215.23 million. Hamilton Lane had a net margin of 32.40% and a return on equity of 23.47%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.54 earnings per share. Analysts anticipate that Hamilton Lane will post 7.47 earnings per share for the current year.
Institutional Trading of Hamilton Lane
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Principal Financial Group Inc. lifted its stake in Hamilton Lane by 1.7% in the first quarter. Principal Financial Group Inc. now owns 1,103,913 shares of the company’s stock valued at $109,725,000 after acquiring an additional 18,063 shares during the last quarter. Janus Henderson Group PLC increased its stake in shares of Hamilton Lane by 12.9% during the 1st quarter. Janus Henderson Group PLC now owns 905,660 shares of the company’s stock worth $90,045,000 after purchasing an additional 103,663 shares during the last quarter. Van Berkom & Associates Inc. increased its stake in shares of Hamilton Lane by 9.7% during the 1st quarter. Van Berkom & Associates Inc. now owns 833,307 shares of the company’s stock worth $82,831,000 after purchasing an additional 73,679 shares during the last quarter. Copeland Capital Management LLC increased its stake in shares of Hamilton Lane by 52.5% during the 3rd quarter. Copeland Capital Management LLC now owns 741,678 shares of the company’s stock worth $64,422,000 after purchasing an additional 255,238 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Hamilton Lane by 1.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 678,579 shares of the company’s stock valued at $67,450,000 after purchasing an additional 12,115 shares during the period. 97.40% of the stock is owned by institutional investors.
Key Hamilton Lane News
Here are the key news stories impacting Hamilton Lane this week:
- Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $120 from $116 and maintained an outperform rating. Wells Fargo also raised its target, to $114 from $103, with an overweight rating. Keefe, Bruyette & Woods price target Wells Fargo price target
- Positive Sentiment: Quarterly EPS of $1.98 beat the $1.65 consensus estimate. Fee-related earnings rose 34%; total assets reached $1.1 trillion, up 7% year over year, while evergreen platform AUM climbed 42% to nearly $21 billion. Q2 2027 earnings call highlights Long-term investor takeaways
- Positive Sentiment: Hamilton Lane raised its dividend for the ninth straight year and outlined a $2.40 fiscal 2027 dividend target, offering support for income-focused investors. Dividend target and partnership
- Neutral Sentiment: JPMorgan cut its target to $144 from $150 but kept an overweight rating; Oppenheimer trimmed its target slightly to $170 from $171 and maintained outperform. Both remain positive on the shares despite the reductions. JPMorgan price target Oppenheimer price target
- Positive Sentiment: A new FactSet partnership aims to provide integrated private-markets analytics, potentially extending Hamilton Lane’s reach and data offering. FactSet partnership announcement
- Negative Sentiment: Revenue of $204.43 million fell short of the $215.23 million consensus, despite growing 7.1% year over year. Coverage also flagged management’s warning about uneven growth and questioned dividend resilience amid a difficult private-markets environment—risks that could help explain continued pressure on the stock. Quarterly results Dividend sustainability analysis
About Hamilton Lane
Hamilton Lane Incorporated (NASDAQ: HLNE) is a global investment management firm specializing in private markets. The company provides investment solutions and advisory services focused on alternative assets, including private equity, private credit, venture capital, growth equity, infrastructure and real assets.
Hamilton Lane serves institutional investors, family offices, financial advisors and high-net-worth individuals. Its offerings include separately managed accounts, customized portfolios, commingled funds, evergreen vehicles and secondary-market strategies.
Further Reading
- Five stocks we like better than Hamilton Lane
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.
